- Home
- XNCR vs CRESY Comparison
XNCR vs CRESY Comparison
Compare XNCR & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- CRESY
- Stock Information
- Founded
- XNCR 1997
- CRESY 1936
- Country
- XNCR United States
- CRESY Argentina
- Employees
- XNCR N/A
- CRESY N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- CRESY Real Estate
- Sector
- XNCR Health Care
- CRESY Finance
- Exchange
- XNCR Nasdaq
- CRESY Nasdaq
- Market Cap
- XNCR 565.1M
- CRESY 664.8M
- IPO Year
- XNCR 2013
- CRESY 1997
- Fundamental
- Price
- XNCR $8.73
- CRESY $11.47
- Analyst Decision
- XNCR Buy
- CRESY
- Analyst Count
- XNCR 7
- CRESY 0
- Target Price
- XNCR $27.50
- CRESY N/A
- AVG Volume (30 Days)
- XNCR 540.9K
- CRESY 163.3K
- Earning Date
- XNCR 08-08-2025
- CRESY 09-08-2025
- Dividend Yield
- XNCR N/A
- CRESY 5.11%
- EPS Growth
- XNCR N/A
- CRESY N/A
- EPS
- XNCR N/A
- CRESY 0.09
- Revenue
- XNCR $127,228,000.00
- CRESY $648,198,954.00
- Revenue This Year
- XNCR N/A
- CRESY N/A
- Revenue Next Year
- XNCR $28.84
- CRESY N/A
- P/E Ratio
- XNCR N/A
- CRESY $11.81
- Revenue Growth
- XNCR N/A
- CRESY N/A
- 52 Week Low
- XNCR $7.16
- CRESY $6.56
- 52 Week High
- XNCR $27.24
- CRESY $14.23
- Technical
- Relative Strength Index (RSI)
- XNCR 47.62
- CRESY 56.85
- Support Level
- XNCR $9.00
- CRESY $10.52
- Resistance Level
- XNCR $9.45
- CRESY $12.03
- Average True Range (ATR)
- XNCR 0.45
- CRESY 0.44
- MACD
- XNCR -0.01
- CRESY 0.12
- Stochastic Oscillator
- XNCR 21.76
- CRESY 69.06
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About CRESY Cresud S.A.C.I.F. y A.
Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.